Skip to main content
Figure 1 | Cardiovascular Diabetology

Figure 1

From: Rosiglitazone reverses endothelial dysfunction but not remodeling of femoral artery in Zucker diabetic fatty rats

Figure 1

The endothelium-dependent dose-response vasorelaxation for the various groups. A: Effect of age (11 wks and 19 wks) on the vasorelaxation of ZDF rats in comparison with lean rats. B: Effects of Rosi on the vasorelaxation of ZDF rats in comparison with lean rats. Lean: Zucker lean rats. ZDF: ZDF rats. Rosi: rosiglitazone treatment. 11w: 11 weeks of age. 19w: 19 weeks of age. #: ANOVA analysis indicates statistical difference (p < 0.05) of the dose-dependent curve between the ZDF rats at different age and lean rats. *: Significant difference (p < 0.05) at single dose between ZDF rats at different age and lean rats.

Back to article page